The Memory Disorders Program is currently recruiting for the following studies.
| Status | Title | Trial Information | Sponsor |
|---|---|---|---|
| Recruiting | Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil (CONCERT) | Trial | Medivation |
| Recruiting | A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer's Disease | Trial | Baxter/ADCS |
| Recruiting | Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease |
Non-Carriers Carriers |
Elan Pharmaceuticals |
| Recruiting | A Trial of V950 in People With Alzheimer's Disease | Trial | Merck |
| Recruiting | Trial Evaluating ACC-001 in Mild to Moderate Alzheimer's Disease Subjects | Trial | Wyeth |